- In November 2024, In November 2024, Philips India launched the Azurion interventional radiology system to enhance procedural capabilities across cardiology, neurology, vascular, and surgical specialties. The system features advanced C-arm rotation, smooth 2D to 3D imaging transitions, and intuitive table-side control, improving workflow efficiency. Integrated AI-powered remote monitoring via the Philips Service Hub helps maintain system performance and minimize downtime. This launch strengthens Philips’ presence in the high-demand interventional radiology segment. It aligns with the growing market preference for precision, speed, and minimally invasive procedures. The system is expected to support faster patient recovery and better outcomes
- In October 2024, the VA Boston Healthcare System unveiled a cutting-edge interventional radiology suite at its West Roxbury campus. The facility is designed to support minimally invasive, image-guided treatments aimed at reducing recovery times and hospital stays for veterans. It features advanced imaging capabilities to ensure precision in diagnosis and therapeutic interventions. The suite marks a strategic upgrade to veteran healthcare, focusing on faster, safer procedures. It also helps reduce procedural complications, aligning with value-based care initiatives. This development underscores the increasing adoption of interventional radiology in public healthcare infrastructure
- In June 2024, GE HealthCare and MediView XR Inc. installed the world’s first OmnifyXR interventional suite at North Star Vascular and Interventional. The system integrates augmented reality and 3D visualization to support minimally invasive procedures with greater accuracy. This innovation improves physician guidance during interventions, enhancing procedural safety and outcomes. It represents a major leap in interventional radiology technology, blending real-time imaging with immersive navigation. The launch aims to appeal to facilities seeking next-gen radiology solutions. It also highlights GE HealthCare’s push to lead in digital transformation within the interventional space
- In June 2024, Royal Philips completed the first implantation of the Duo Venous Stent System to treat venous outflow obstruction in patients with chronic venous insufficiency. The procedure followed U.S. FDA premarket approval and represents a significant advancement in vascular interventional care. The device is designed for durability and flexibility, improving long-term vein patency. This launch enhances Philips’ vascular portfolio and affirms its innovation leadership in minimally invasive solutions. The new stent system is expected to improve patient outcomes and reduce the need for repeat interventions. Its entry into the market supports Philips’ strategic expansion in therapeutic radiology
